What type of study is this?

September 19, 2025The Pediatric Infectious Disease Journal

Analysis of Pharmacokinetics and Comparison Between One-point versus Two-point Sampling for Therapeutic Drug Monitoring of Vancomycin in Children

View Full Paper

Ask AI

Bookmark

AUC-based vancomycin dosing was linked to a lower incidence of AKI in pediatric patients, indicating its potential advantage.
The study included 288 pediatric patients, revealing no significant difference in AUC estimation using 1-point versus 2-point sampling.
Pharmacokinetic parameters were estimated using Bayesian software, emphasizing modern techniques for TDM.
Findings suggest AUC-guided dosing may optimize therapeutic outcomes without increasing AKI risk in children.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Retrospective cohort study finds no significant differences between sampling methods for AUC estimation, implicating vancomycin's role in reducing acute kidney injury.

Cite This Study

Yoon et al. (2025) studied this question.

synapsesocial.com/papers/68d464e031b076d99fa63e0f https://doi.org/10.1097/inf.0000000000005006

View Full Paper

Ask AI

Bookmark

Implication

Retrospective cohort study finds no significant differences between sampling methods for AUC estimation, implicating vancomycin's role in reducing acute kidney injury.

Analysis of Pharmacokinetics and Comparison Between One-point versus Two-point Sampling for Therapeutic Drug Monitoring of Vancomycin in Children

Key Points

Discussion

Implication

Cite This Study

Analysis of Pharmacokinetics and Comparison Between One-point versus Two-point Sampling for Therapeutic Drug Monitoring of Vancomycin in Children

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider